Strategic Pivot Propeller Health has ceased operations as an independent entity and is being retained as part of ResMed, creating a pathway for ResMed to introduce Propeller’s digital health capabilities within its broader sleep, breathing, and home care solutions. This presents opportunities to upsell Propeller’s platform to existing ResMed customers.

Financial Backing Recent Series C financing including new investor 3M Ventures signals strong validation and potential for increased investment in Propeller’s digital health platform. Leverage this momentum to position cross-sell of data analytics, population health, and adherence tools to scaling health systems and payers.

Clinical Footprint Propeller has demonstrated impact in improving inhaler adherence and reducing rescue use through partnerships with healthcare providers and payers. Target health systems, specialty clinics, and pharmaceutical collaborations seeking digital adherence solutions and real-world evidence generation.

Partnership Synergy Existing and historical collaborations with Novartis, Desert Oasis Healthcare, and global distributors suggest a network-ready for expanded digital health deployments. Develop joint go-to-market with pharma and pharma-adjacent channels to embed Propeller within asthma and COPD care pathways.

Growth Reach With a lean headcount yet notable funding and a broad tech stack, there is capacity for scalable implementations through ResMed’s enterprise sales channels and global footprint. Focus on enterprise clients, payer programs, and hospital systems seeking digital respiratory care modernization.